Micreos starts trial of first endolysin-drug for atopic dermatitis
BBC Two - Trust Me, I'm a Doctor, Series 6, Episode 2 - Could enzymes called endolysins ease eczema symptoms and offer an alternative to antibiotics?
Gladskin HCP
Gladskin introduces new eczema cream
Dutch Biotech Touts Enzyme-Powered Eczema Cream As 'Smarter And Safer' Solution :: HBW Insight
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
Viruses | Free Full-Text | The Advantages and Challenges of Using Endolysins in a Clinical Setting
New Gladskin Eczema Cream Is Based on Three Billion Years of Nature's Work
How to treat eczema: New breakthrough study proves certain products can improve quality of life
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms - Micreos.com
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
Gladskin: Rethinking Skincare & Restoring Skin Health
NEW STUDY: Gladskin ingredient Staphefekt™ found to significantly redu
Micreos raises €30 Million for endolysin technology set to replace antibiotics - Hub Publishing
Staphefekt™ by Micreos
Linker-Improved Chimeric Endolysin Selectively Kills Staphylococcus aureus In Vitro, on Reconstituted Human Epidermis, and in a Murine Model of Skin Infection | Antimicrobial Agents and Chemotherapy
New treatment option for eczema patients: Clinical study proves safe anti-S. aureus endolysin 'Staphefekt SA.100' significantly reduces eczema symptoms
How Gladskin found their shipping problem solution - MESA
Phages: the natural enemy of bacteria that help tackle skin conditions | NLO
New Gladskin Eczema Cream Is Based on Three Billion Years of Nature's Work
staphefekt - Twitter Search / Twitter
The Science: Eczema Cream With Micreobalance™ | Gladskin
REVIEW Gladskin Eczema - Does It Work? | EndolysinCream
Micreos Raises €30 Million for Endolysin Technology Set to Replace Antibiotics
Topical S. aureus - Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis - JDDonline - Journal of Drugs in Dermatology
Are Phage Lytic Proteins the Secret Weapon To Kill Staphylococcus aureus? | mBio
Topical S. aureus - Targeting Endolysin Significantly Improves Symptoms and QoL in Individuals With Atopic Dermatitis - JDDonline - Journal of Drugs in Dermatology
